Publications (21) Publications in which a researcher has participated

2017

  1. Assessment of the Clinical Performance of Platelet Concentrates Treated by Pathogen Reduction Technology in Santiago de Compostela

    Transfusion Medicine and Hemotherapy, Vol. 44, Núm. 1, pp. 5-9

  2. Autologous Stem Cell Transplantation for Follicular Lymphoma: Favorable Long-Term Survival Irrespective of Pretransplantation Rituximab Exposure

    Biology of Blood and Marrow Transplantation, Vol. 23, Núm. 10, pp. 1631-1640

  3. Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO)

    Annals of Hematology, Vol. 96, Núm. 8, pp. 1323-1330

  4. Clinical outcomes of 217 patients with acute erythroleukemia according to treatment type and line: A retrospective multinational study

    International Journal of Molecular Sciences, Vol. 18, Núm. 4

  5. Collection, storage, inspection and quality control of platelet concentrates obtained by apheresis: The situation in Spain

    Transfusion and Apheresis Science, Vol. 56, Núm. 3, pp. 357-361

  6. Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in spain

    ClinicoEconomics and Outcomes Research, Vol. 9, pp. 39-47

  7. Donor CTLA-4 Genotype Modulates the Immune Response to Minor Histocompatibility Antigen Mismatches

    Biology of Blood and Marrow Transplantation, Vol. 23, Núm. 12, pp. 2042-2047

  8. EARLY DETECTION OF HEMOGLOBINOPATHIES IN "PREGNANT WOMEN AT RISK"

    HAEMATOLOGICA, Vol. 102, Núm. Supl. 4, pp. 145

  9. Further psychometric validation of the GAH scale: Responsiveness and effect size

    Journal of Geriatric Oncology, Vol. 8, Núm. 3, pp. 211-215

  10. INFECCION NOSOCOMIAL EN LA UNIDAD DE HOSPITALIZACION DE HEMATOLOGIA. ANALISIS DESCRIPTIVO Y FACTORES DE RIESGO

    HAEMATOLOGICA, Vol. 102, Núm. Supl. 4, pp. 252-253

  11. Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma

    Blood

  12. Molecular and clinical profile of von willebrand disease in Spain (PCM-EVW-ES): Comprehensive genetic analysis by next-generation sequencing of 480 patients

    Haematologica, Vol. 102, Núm. 12, pp. 2005-2014

  13. ORBITAL CHLOROMA AND T(8;21)

    HAEMATOLOGICA, Vol. 102, Núm. Supl. 4, pp. 169

  14. Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis

    European Journal of Haematology, Vol. 98, Núm. 4, pp. 407-414

  15. Progression-free survival at 2 years post-autologous transplant: a surrogate end point for overall survival in follicular lymphoma

    Cancer Medicine, Vol. 6, Núm. 12, pp. 2766-2774

  16. Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 8, pp. 2359-2367

  17. Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea

    Haematologica, Vol. 102, Núm. 1, pp. 103-109

  18. Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group

    British Journal of Haematology, Vol. 178, Núm. 5, pp. 699-708

  19. TRATAMIENTO SEGÚN ESQUEMA R-MINICHOP EN PACIENTES ANCIANOS DIAGNOSTICADOS DE LINFOMA DIFUSO DE CÉLULAS GRANDES B (LBCG): LA EXPERIENCIA EN NUESTRO CENTRO

    HAEMATOLOGICA, Vol. 102, Núm. Supl. 4, pp. 227-228

  20. The mitochondrial inhibitor oligomycin induces an inflammatory response in the rat knee joint

    BMC Musculoskeletal Disorders, Vol. 18, Núm. 1